Current epidemiology of viral hepatitis: Who is affected and who can be protected?;Epidemiología actual de las hepatitis virales: ¿Quién las padece y quién puede protegerse?

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 22, Issue 8, 2004, Pages 443-447

  Bruguera, Miquel ^a,b   Forns, Xavier ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN;

AGE; DRUG DEPENDENCE; EDITORIAL; GENETIC IDENTIFICATION; HEMODIALYSIS; HEPATITIS A; HEPATITIS A VIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HIGH RISK POPULATION; HOMOSEXUALITY; HUMAN; INCIDENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MORBIDITY; MORTALITY; POLITICS; PREVALENCE; PUBLIC HEALTH SERVICE; QUALITY OF LIFE; RISK FACTOR; RISK REDUCTION; SPAIN; SYMPTOM; VIRUS HEPATITIS; VIRUS IDENTIFICATION; VIRUS TRANSMISSION;

EID: 8644251329     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13066849     Document Type: Editorial

References (78)

1. Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. N Engl J Med 1997;356:196-204.
2. Bruguera M, Salleras L, Plans P, Vidal J, Navas E, Domínguez A. Cambios en la seroepidemiología de la infección por el virus de la hepatitis A en Cataluña en el período 1989-96. Implicaciones para una nueva estrategia vacunal. Med Clin (Barc) 1999;42:406-8.
3. Mele A, Stroffolini T, Palumbo F, Gallo G, Ragni P, Balocchini E, et al. Incidence and risk factors for hepatitis A in Italy: public health indications from a 10-year surveillance. J Hepatol 1997;26:743-7.
4. Domínguez A, Vidal J, Bruguera M, Salleras L. Epidemiología de las hepatitis virales. Enferm Infecc Microbiol Clin 1995;13(Supl 1):50-61.
5. Mast EE, Mahoney FJ, Alter MJ, Margoulis HS. Progress toward elimination of hepatitis B virus transmission in the United States. Vaccine 1998;16: S48-S51.
6. Alter MJ, Kruszon D, Naiman OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1883 through 1994. N Engl J Med 1999;341:556-62.
7. Koff RS. Hepatitis A. Lancet 1998;351:1643-9.
8. Berthelot P. Hépatite virale A: une epidemiologie mouvante qui va faire changer nos concepts. Gastroenterol Clin Biol 1992;16:669-70.
9. Salleras L, Bruguera M, Vidal J, Taberner JL, Plans P, Jiménez de Anta MT, et al. Cambio en el patrón epidemiológico de la hepatitis A en España. Med Clin (Barc) 1992;99:87-9.
10. Vargas V, Hernández-Sánchez JM, Viladoms J, Esteban R, Pedreira JD, Guardia J, et al. Prevalencia de los anticuerpos frente al antígeno de la hepatitis A (anti-VHA) en la población general. Med Clin (Barc) 1979;73:274-6.
11. Salleras L, Bruguera M, Buti M, Domínguez A, Vidal J, Navas E, et al. Hepatitis A vaccination policy in Catalonia (Spain). Vacunas 2000;1:48-57.
12. Ciccozzi M, Tosti ME, Gallo G, Ragni P, Zotti C, Lopalco P, et al. Risk of hepatitis A infection following travel. J Viral Hep 2002;9:460.
13. Romalde JL, Torrado I, Ribao C, Barja JR. Global market shellfish imports as a source of reemerging food-borne hepatitis A virus infection in Spain. Int Microbiol 2001;4:223-6.
14. Pañella H, Bayas JM, Maldonado R, Cayla JA, Vilella A, Sala C, et al. Brote epidémico de hepatitis A relacionado con una guardería infantil. Gastroenterol Hepatol 1998;21:319-23.
15. Junquera S, Mateos M, Lasa E, Chacón de Antonio J, Baquero F. Estudio seroepidemiológico de Hepatitis A en la Comunidad de Madrid durante el año 2002. Enferm Infecc Microbiol Clin 2004;22:448-51.
16. Bruguera M, Buti M, Diago M, García Bengoechea M, Jara P, Pedreira JD, et al. Indicaciones y prescripción de la vacuna de la hepatitis A en España. Informe de la AEEH. Med Clin (Barc) 1998;11:341-6.
17. Bell BP, Shapiro CN, Alter MJ, Moyer LA, Judson FN, Mottram K, et al. The diverse patterns of hepatitis A epidemiology in the United States- Implications for vaccination strategies. J Infect Dis 1998;178:1579-84.
18. Craig AS, Schaffner W. Clinical practice. Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med 2004;350:476-81.
19. Rosenthal P. Cost-effectiveness of hepatitis A vaccination in children, adolescents, and adults. Hepatology 2003;37:44-51.
20. Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998;338:286-90.
21. Domínguez A, Bruguera M, Vidal J, Plans P, Salleras L. Change in the epidemiology of hepatitis B infection in Catalonia, 1989-1996. Vaccine 2000;18:2345-50.
22. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-90.
23. Echevarria JM, León P. Hepatitis B vitus genotype identified by a Line Probe Assay (LiPA) amog chronic carriers from Spain. Enferm Infecc Microbiol Clin 2004;22:452-4.
24. Álvarez M, Oyonarte S, Rodríguez PM, Hernández JM. Estimated risk of transfusion-transmitted viral infections in Spain. Transfusion 2002;42:994-8.
25. Bruguera M. Hepatitis en drogadictos. Med Clin (Barc) 1984;82:21-4.
26. Hadler SC, Doto II, Maynard JE, Smith J, Clark B, Mosley J, et al. Occupational risk of hepatitis B infection in hospital workers. Infection Control 1985;6:24-31.
27. Hutin YJ, Goldstein ST, Varma JK, O'Dair JB, Mast EE, Shapiro CN, et al. An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis. Infect Control Hosp Epidemiol 1999;20:731-5.
28. Bayas JM, Bruguera M, Martín V, Vidal J, Rodés J, Salleras L. Hepatitis B vaccination in prisons. The Catalonian experience. Vaccine 1993;11:1441-4.
29. Mahoney FJ, Stewart K, Hu H, Coleman P, Alter MJ. Progress toward the elimination of hepatitis B virus transmission among health care workers in United States. Arch Intern Med 1997;157:2601-5.
30. Miller ER, Alter MJ, Tokars JI. Protective effect of hepatitis B vaccine in chronic hemodialysis patients. Am J Kidney Dis 1999;33:356-60.
31. Heptonstall J. Outbreak of hepatitis B infection associated with infected surgical staff. Comm Dis Rep 1991;1:r81-5.
32. Prentice MB, Flower AJE, Morgan GM, Nicholson KG, Rana B, Firmin RK, et al. Infection with hepatitis B virus after open heart surgery. BJM 1992;304:761-4.
33. Harpaz R, Von Seidlin L, Averhoff FM, Tormey MP, Sinha SD, Kotsopoulou K, et al. Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med 1996;334:549-54.
34. The incident investigation team and others. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen. N Engl J Med 1997;336:178-84.
35. Drescher J, Wagner D, Haverich A, Flik J, Stachan-Kunstyr R, Verhagen W, et al. Nosocomial hepatitis B virus infection in cardiac transplant recipients transmitted during transvenous endomyocardial biopsy. J Hosp Infect 1994;26:81-92.
36. Polish LB, Shapiro CN, Bauer F, Klotz P, Ginier P, Roberto RR, et al. Nosocomial transmission of hepatitis B virus associated with spring-loaded fingerstick device. N Engl J Med 1992;326:721-5.
37. Rimland D, Parkin WE, Miller GB, Schrack WD. Hepatitis B outbreak traced to an oral surgeon. N Engl J Med 1977;296:953-8.
38. Hadler SC, Sorley DL, Acree KH, Websler HM, Schable LA, Francis DP, et al. An outbreak of hepatitis B in dental practice. Ann Intern Med 1981;95:133-8.
39. Levin ML, Maddrey WC, Wands JR, Mendeloff AI. Hepatitis B transmission by dentists. JAMA 1974;228:1139-40.
40. Centers for Diseases Control and Prevention. Updated USPHS guidelines for managing occupational exposures to HBV, HVC, and HIV and considerations for dentistry. J Am Dent Assoc 2002;133:1627-9.
41. Alter MJ, Margolis HS. The emergence of hepatitis B as a sexually transmitted disease. Med Clin North Am 1990;74:1529-41.
42. Diamond C, Thiede H, Perdue T, Secura GM, Valleroy L, Mackellar D, et al. Viral hepatitis among young men who have sex with men: prevalence, risk behaviours, and vaccination, Sex Transm Dis 2003;30:425-32.
43. Traen A, Claessens M, Van Rentrghem L, Leroux-Roels G, Van Damme P. Hepatitis B vaccination for sex workers: do outreach programmes perform better? Sex Transm Infect 2003;79:157-9.
44. Sansom S, Rudy E, Strine T, Douglas W. Hepatitis A and B vaccination in a sexually transmitted diseases clinic for men who have sex with men. Sex Transm Dis 2003;30:685-8.
45. Hong-Yuang H, Mei-Hwei C, Chin-Yun I. Precore mutant of hepatitis B virus in childhood viral hepatitis B: an infrequent association. J Infect Dis 1995;171:776-81.
46. Degos F. Vaccination contre le VHB: les experts de l'INSERM et de l'ANAES prennent position. Gastroenterol Clin Biol 2004;28:50-3.
47. Fábregas E, García Suárez C, Guerra A, Orive A, Casafont F, Crespo J, et al. Liver transplantation with allografts from hepatitis B core antibody-positive donors: a new approach. Liver Transpl 2003;9:916-20.
48. Bruguera M, Sánchez Tapias JM. Hepatitis vírica en población inmigrada y en niños adoptados. Un problema de magnitud desconocida en España. Med Clin (Barc) 2001;117:595-6.
49. Salleras L, Bruguera M, Vidal J, Taberner JL, Plans P, Bayas JM, et al. Prevalence of hepatitis B serologic markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents. Eur J Epidemiol 1992;8:640-4.
50. Kane M. Status of hepatitis B immunisation programmes in 1998. Vaccine 1998;16:S104-S8.
51. Lin HH, Wang LY, Hu CT, Huang SC, Huang LC, Lin SS, et al. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol 2003;69:471-4.
52. Kao JH, Hsu HM, Sau WY, Chang MH, Chen DS. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediat 2001;139:349-52.
53. Chen HL, Chang CJ, Kong MI, Huang FC, Lee HC, Liu CC, et al. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection 15 years after universal hepatitis B vaccination. Hepatology 2004;39:58-63.
54. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood hepatoma study group. N Engl J Med 1997;336:1855-9.
55. Da Villa G. Rationales for the infant and adolescent vaccination programmes in Italy. Vaccine, 2000;18:S31-S4.
56. Salleras L, Bruguera M, Taberner JL, Domínguez A, Batalla J, Buti M, et al. Efectividad del programa masivo de vacunación antihepatitis B de los preadolescentes en las escuelas de Cataluña. Med Clin (Barc) 2003;121(Supl 1): 79-82.
57. Ray Kim W. The burden of hepatitis C in the United States. Hepatology 2002;36(Suppl 1):30-4.
58. Stramer SL, Caglioti S, Strong DM. NAT of the United States and Canadian blood supply. Transfusion 2000;40:1165-8.
59. Alter MJ. Prevention of spread of hepatitis C. Hepatology 2002;36(Suppl 1): 93-8.
60. Martínez Bauer E, Forns X, García-Retortillo M, Martín M, Feiu A, Navasa M, et al. A prospective study of nosocomial transmission of hepatitis C virus in the Liver unit of a tertiary care center. J Hepatol 2003;38:(Suppl 2):32.
61. Lamballerie X, Olmer M, Bouchonareb D, Zandotti C, De Miccio P. Nosocomial transmission of hepatitis C virus a haemodialysis patients. J Med Virol 1996;49:296-302.
62. McLaughlin KT, Cameron SQ, Good T, McCruden E, Fergusson JC, Davidson F, et al. Nosocomial transmission of hepatitis C virus within a British dialysis center. Nephrol Dial Transplant 1997;12:304-9.
63. Kokubo S, Horii T, Yonekawa O, Ozawa N, Mukaide M. A phylogenetic-tree analysis elucidating nosocomial transmission of hepatitis C virus in a haemodialysis unit. J Viral Hep 2002;9:450-4.
64. Forns X, Fernández-Llama P, Pons M, Costa J, Ampurdanés S, López Labrador FX, et al. Incidence and risk factors of hepatitis C virus infection in a hemodialysis unit. Nephrol Dial Transplant 1997;12:736-40.
65. Okuda K, Hayashi H, Kitayashi S, Irie Y. Mode of hepatitis C virus transmission not associated with blood transfusion among chronic haemodialysis patients. J Hepatol 1995;23:28-31.
66. Alfuray O, Sabeal A, Al Ahdal MN, Almeshari K, Kessie G, Hamid M. Hand contamination with hepatitis C virus in staff after looking hepatitis C positive hemodialysis patients. Am J Nephrol 2000;20:103-6.
67. Bronowicki JP, Venard V, Botte C, Monhoven N, Gastin V, Robin E, et al. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med 1997;337:237-40.
68. Bruguera M, Saiz JC, Franco S, Giménez-Barcons M, Sánchez Tapias JM, Fabregas S, et al. Outbreak of nosocomial hepatitis C virus infection resolved by genetic analysis of HCV RNA. J Clin Microbiol 2002;40:4363-6.
69. Tallis GF, Ryan GM, Lambert SB, Bowden DS, McCaw R, Birch CJ, et al. Evidence of patient-to-patient transmission of hepatitis C virus through contaminated intravenous anaesthetic ampoules. J Viral Hep 2003;10:234-40.
70. Krause G, Trepka MJ, Whisenhunt RS, Katz D, Nainan O, Wiersma Hopkins RS. Nosocomial transmission of hepatitis C virus associated with use of multidose saline vials. Infect Control Hosp Epidemiol 2003;24:122-7.
71. Esteban JI, Gómez J, Martell M, Cabot B, Quer J, Camps J, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996;334:555-60.
72. Brown P. Surgeon infects patient with hepatitis C. Brit Med J 1999;319:1219.
73. Duckworth GH, Heptonstall J, Aktken C. Transmission of hepatitis from a surgeon to a patient. Commun Dis Public Health 1999;2:188-92.
74. Ross RS, Viazov S, Thormahlen M, Bartz L, Tamn J, Rautenberg P, et al. Risk of hepatitis C virus transmission from an infected gynaecologist to patients: results of a 7-year look-back investigation. Arch Intern Med 2002;162:805-10.
75. Cody SH, Nainan OV, Garfein RS, Meyers H, Bell BP, Shapiro CN, et al. Hepatitis C virus transmission from an anaesthesiologist to a patient. Arch Intern Med 2000;343:1851-4.
76. Ross RS, Viazov S, Roggendorf M. Risk of hepatitis C transmission from infected medical staff to patients. Model-based calculations for surgical settings. Arch Intern Med 2000;160:2313-6.
77. Vandrelli C, Renzo F, Romano L, Tisminetzky S, De Palma M, Stroffolini T, et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: Results of a 10 year prospective follow-up study. Am J Gastroenterol, 2004 [en prensa].
78. Gibb DM, Goodall RL, Dunn DT, Healey M, Neave P, Cafferkey M, et al. Mother-to-child transmission of hepatitis C virus: evidence for preventive peripartum transmission. Lancet 2000;356:904-7.